The importance of natural product characterization in studies of their anti-inflammatory activity

被引:66
作者
Gosslau, Alexander [1 ,2 ]
Li, Shiming [2 ]
Ho, Chi-Tang [3 ]
Chen, Kuang Yu [1 ]
Rawson, Nancy E. [2 ,4 ]
机构
[1] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA
[2] WellGen Inc, Commercializat Ctr Innovat Technol, N Brunswick, NJ USA
[3] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08903 USA
[4] AFB Int, St Charles, MO USA
关键词
Disease; Inflammation; Natural products; Polymethoxyflavones; Polyphenols; NF-KAPPA-B; BLACK TEA; CANCER PREVENTION; OXIDATIVE STRESS; NITRIC-OXIDE; ORANGE PEEL; INFLAMMATION; NOBILETIN; CELLS; MOUSE;
D O I
10.1002/mnfr.201000455
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The knowledge that natural products provide a rich source for therapeutic discovery has led to the development of many of the world's most commonly used drugs. In view of the growing need for effective anti-inflammatory agents, the potential for natural products to serve as safe and effective therapeutic agents has gained increasing attention. However, polymolecular extracts must be rigorously evaluated and chemically characterized to insure adequate consistency in performance. The research in this field has been plagued by inconsistencies due in part to inadequate chemical characterization and documentation, making comparison of results across studies very difficult. Analytical chemistry and molecular methods now exist to insure sufficient transparency to avoid this limitation. Further, our understanding of the complexity of inflammation has advanced to enable significant insight into the mechanism of action of these natural extracts. Here, we review the inflammatory pathways targeted by many therapeutic agents, discuss the value of natural products as anti-inflammatory agents, review approaches for their biological and chemical evaluation, and highlight challenges to the field. We present two examples highlighting the rigorous use of cell, molecular, and chemical methods for characterization and quality control as templates for future studies of anti-inflammatory activity of natural products.
引用
收藏
页码:74 / 82
页数:9
相关论文
共 56 条
  • [1] Inflammation and cancer: How hot is the link?
    Aggarwal, Bharat B.
    Shishodia, Shishir
    Sandur, Santosh K.
    Pandey, Manoj K.
    Sethi, Gautam
    [J]. BIOCHEMICAL PHARMACOLOGY, 2006, 72 (11) : 1605 - 1621
  • [2] Inflammation and cancer: how friendly is the relationship for cancer patients?
    Aggarwal, Bharat B.
    Gehlot, Prashasnika
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2009, 9 (04) : 351 - 369
  • [3] Advanced glycation endproducts: what is their relevance to diabetic complications?
    Ahmed, N.
    Thornalley, P. J.
    [J]. DIABETES OBESITY & METABOLISM, 2007, 9 (03) : 233 - 245
  • [4] Theaflavin, a black tea extract, is a novel anti-inflammatory compound
    Aneja, R
    Odoms, K
    Denenberg, AG
    Wong, HR
    [J]. CRITICAL CARE MEDICINE, 2004, 32 (10) : 2097 - 2103
  • [5] The effects of theaflavin-enriched black tea extract on muscle soreness, oxidative stress, inflammation, and endocrine responses to acute anaerobic interval training: a randomized, double-blind, crossover study
    Arent, Shawn M.
    Senso, Meghan
    Golem, Devon L.
    McKeever, Kenneth H.
    [J]. JOURNAL OF THE INTERNATIONAL SOCIETY OF SPORTS NUTRITION, 2010, 7
  • [6] OPINION Is NF-κB a good target for cancer therapy? Hopes and pitfalls
    Baud, Veronique
    Karin, Michael
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (01) : 33 - 40
  • [7] Molecular and cellular targets
    Bode, Ann M.
    Dong, Zigang
    [J]. MOLECULAR CARCINOGENESIS, 2006, 45 (06) : 422 - 430
  • [8] Chen D, 2008, HISTOL HISTOPATHOL, V23, P487, DOI 10.14670/HH-23.487
  • [9] Leukotriene A4 hydrolase as a target for cancer prevention and therapy
    Chen, X
    Wang, S
    Wu, N
    Yang, CS
    [J]. CURRENT CANCER DRUG TARGETS, 2004, 4 (03) : 267 - 283
  • [10] Correlation between flavonoid content and the NO production inhibitory activity of peel extracts from various citrus fruits
    Choi, Soo-Youn
    Ko, Hee-Chul
    Ko, Soo-Youn
    Hwang, Joon-Ho
    Park, Ji-Gweon
    Kang, Shin-Hae
    Han, Sang-Hun
    Yun, Su-Hyun
    Kim, Se-Jae
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2007, 30 (04) : 772 - 778